Quality Chemical Industries Limited

Not to be confused with Quality Chemicals Limited.
Quality Chemical Industries Limited
FormerlyCipla Quality Chemical Industries Limited - CiplaQCIL
Company typePublic
USE: QCIL
IndustryPharmaceutical Industry
FoundedJuly 10, 2005 (2005-07-10)
HeadquartersLuzira, Kampala, Uganda
Area served
Africa
Key people
Emmanuel Katongole
Executive Chairman
Ajay Kumar Pal
Chief Executive Officer
ProductsPharmaceuticals
Revenue:USh265.3 billion (US$70.9 million) (March 2024)
Total assetsUSh232.0 billion (US$60.1 million) (March 2024)
Number of employees
580+ (2025)
Websitewww.qcil.com

Quality Chemical Industries Limited (QCIL), formerly Cipla Quality Chemical Industries Limited (CiplaQCIL) is a pharmaceutical manufacturing company, established in Uganda in 2005. The company is the largest producer of World Health Organization (WHO) pre-qualified HIV/AIDS and malaria treatments in the region. According to a 2007 published report, QCIL was the only company in Africa to manufacture triple-combination antiretroviral (ARV) drugs. QCIL currently produces TLD (a combination of tenofovir, lamivudine and dolutegravir), the latest first-line treatment used to treat and prevent HIV/AIDS. QCIL also manufactures antimalarials (ACTs), including Lumartem, containing artemisinin and lumefantrine, and the Hepatitis B generic medicines Texavir and Zentair.

The company also manufactures antibacterials, anti-hypertensives, vasodilators, anti-emetics, antibiotics and antidiabetics.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.